426 related articles for article (PubMed ID: 11078768)
1. Safety of withholding heparin in pregnant women with a history of venous thromboembolism. Recurrence of Clot in This Pregnancy Study Group.
Brill-Edwards P; Ginsberg JS; Gent M; Hirsh J; Burrows R; Kearon C; Geerts W; Kovacs M; Weitz JI; Robinson KS; Whittom R; Couture G;
N Engl J Med; 2000 Nov; 343(20):1439-44. PubMed ID: 11078768
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of prophylactic low molecular weight heparin in pregnant women with a prior history of venous thromboembolism.
Johnston JA; Brill-Edwards P; Ginsberg JS; Pauker SG; Eckman MH
Am J Med; 2005 May; 118(5):503-14. PubMed ID: 15866253
[TBL] [Abstract][Full Text] [Related]
3. Venous thromboembolism during pregnancy or postpartum: findings from the RIETE Registry.
Blanco-Molina A; Trujillo-Santos J; Criado J; Lopez L; Lecumberri R; Gutierrez R; Monreal M;
Thromb Haemost; 2007 Feb; 97(2):186-90. PubMed ID: 17264945
[TBL] [Abstract][Full Text] [Related]
4. The incidence and risk factors of recurrent venous thromboembolism during pregnancy.
Galambosi PJ; Ulander VM; Kaaja RJ
Thromb Res; 2014 Aug; 134(2):240-5. PubMed ID: 24835671
[TBL] [Abstract][Full Text] [Related]
5. A risk score for the management of pregnant women with increased risk of venous thromboembolism: a multicentre prospective study.
Dargaud Y; Rugeri L; Vergnes MC; Arnuti B; Miranda P; Negrier C; Bestion A; Desmurs-Clavel H; Ninet J; Gaucherand P; Rudigoz RC; Berland M; Champion F; Trzeciak MC
Br J Haematol; 2009 Jun; 145(6):825-35. PubMed ID: 19388925
[TBL] [Abstract][Full Text] [Related]
6. Sex and gender issues and venous thromboembolism.
Moores L; Bilello KL; Murin S
Clin Chest Med; 2004 Jun; 25(2):281-97. PubMed ID: 15099889
[TBL] [Abstract][Full Text] [Related]
7. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer.
Lee AY; Levine MN; Baker RI; Bowden C; Kakkar AK; Prins M; Rickles FR; Julian JA; Haley S; Kovacs MJ; Gent M;
N Engl J Med; 2003 Jul; 349(2):146-53. PubMed ID: 12853587
[TBL] [Abstract][Full Text] [Related]
8. Prediction, prevention, and treatment of venous thromboembolic disease in pregnancy.
Zotz RB; Gerhardt A; Scharf RE
Semin Thromb Hemost; 2003 Apr; 29(2):143-54. PubMed ID: 12709917
[TBL] [Abstract][Full Text] [Related]
9. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.
Kearon C; Gent M; Hirsh J; Weitz J; Kovacs MJ; Anderson DR; Turpie AG; Green D; Ginsberg JS; Wells P; MacKinnon B; Julian JA
N Engl J Med; 1999 Mar; 340(12):901-7. PubMed ID: 10089183
[TBL] [Abstract][Full Text] [Related]
10. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group.
Schulman S; Granqvist S; Holmström M; Carlsson A; Lindmarker P; Nicol P; Eklund SG; Nordlander S; Lärfars G; Leijd B; Linder O; Loogna E
N Engl J Med; 1997 Feb; 336(6):393-8. PubMed ID: 9010144
[TBL] [Abstract][Full Text] [Related]
11. Thrombophilic abnormalities and recurrence of venous thromboembolism in patients treated with standardized anticoagulant treatment.
Santamaria MG; Agnelli G; Taliani MR; Prandoni P; Moia M; Bazzan M; Guazzaloca G; Ageno W; Bertoldi A; Silingardi M; Tomasi C; Ambrosio GB;
Thromb Res; 2005; 116(4):301-6. PubMed ID: 16038714
[TBL] [Abstract][Full Text] [Related]
12. Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism. Duration of Anticoagulation Trial.
Schulman S; Lindmarker P
N Engl J Med; 2000 Jun; 342(26):1953-8. PubMed ID: 10874063
[TBL] [Abstract][Full Text] [Related]
13. Electronic alerts to prevent venous thromboembolism among hospitalized patients.
Kucher N; Koo S; Quiroz R; Cooper JM; Paterno MD; Soukonnikov B; Goldhaber SZ
N Engl J Med; 2005 Mar; 352(10):969-77. PubMed ID: 15758007
[TBL] [Abstract][Full Text] [Related]
14. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium.
Gerhardt A; Scharf RE; Beckmann MW; Struve S; Bender HG; Pillny M; Sandmann W; Zotz RB
N Engl J Med; 2000 Feb; 342(6):374-80. PubMed ID: 10666427
[TBL] [Abstract][Full Text] [Related]
15. Pregnancy-related recurrent events in thrombophilic women with previous venous thromboembolism.
Simioni P; Tormene D; Prandoni P; Girolami A
Thromb Haemost; 2001 Sep; 86(3):929. PubMed ID: 11583329
[No Abstract] [Full Text] [Related]
16. The management of thrombosis in pregnancy: role of low-molecular-weight heparin.
Kher A; Bauersachs R; Nielsen JD
Thromb Haemost; 2007 Apr; 97(4):505-13. PubMed ID: 17393011
[TBL] [Abstract][Full Text] [Related]
17. The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis.
De Stefano V; Martinelli I; Rossi E; Battaglioli T; Za T; Mannuccio Mannucci P; Leone G
Br J Haematol; 2006 Nov; 135(3):386-91. PubMed ID: 16984390
[TBL] [Abstract][Full Text] [Related]
18. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
Kakkar VV; Howes J; Sharma V; Kadziola Z
Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
[TBL] [Abstract][Full Text] [Related]
19. Thrombosis, thrombophilia, and thromboprophylaxis in pregnancy.
James AH; Brancazio LR; Ortel TL
Clin Adv Hematol Oncol; 2005 Mar; 3(3):187-97. PubMed ID: 16166990
[TBL] [Abstract][Full Text] [Related]
20. Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis.
Breddin HK; Hach-Wunderle V; Nakov R; Kakkar VV;
N Engl J Med; 2001 Mar; 344(9):626-31. PubMed ID: 11228276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
